Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Collins (NPI 1225477425)

Field	Value
Entity Type	Individual
Organization	Robert Collins
Address	1801 Sunset
City	Columbia
State	SC
ZIP	29203
Taxonomy	Internal Medicine Physician
NPI Enumerated	June 20, 2013

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: lifetime Medicare revenue is $2.7M and there is no Medicaid billing on file, indicating Medicare dominates the practice’s public‑payer volume and reimbursement profile. Analysts should treat this as a Medicare‑centric billing footprint rather than a dual‑payer operation.

Revenue is highly concentrated in a few drugs and infused therapies: J9271 ($860K, 33.8%), J0897 ($409.3K, 16.1%), and J1930 ($359K, 14.1%) together account for 64.0% of the provider’s total Medicare revenue. This concentration implies the practice’s financial performance is closely tied to a small set of high‑value injectable therapies.

The code mix points to an infusion‑ and oncology‑oriented service line despite the provider’s Internal Medicine Physician taxonomy: top codes include J9271 (pembrolizumab), J0897 (denosumab), and J1930 (lanreotide), and the portfolio also contains chemotherapy administration codes (96413, 96365, 96367) plus PET/CT imaging (78815, 78816). Together these codes are consistent with on‑site infusion services and cancer treatment workflows rather than a pure primary care panel.

Competitive standing is mixed across those top codes: J0897 ranks #211 of 10057 providers (98th percentile) and is labeled notably above typical national volume, signaling a strong national presence for denosumab administration. By contrast, J9271 ranks #396 of 1841 providers (78th percentile) and J1930 ranks #12 of 56 providers (80th percentile), both described as typical, unremarkable volume; this suggests market leadership for some specific drugs but otherwise conventional positioning.

Evaluation-and-management activity is unusually high: 99214 shows 2.2K claims with $194.6K revenue and is described as an extreme outlier, far above typical national volume. High 99214 volume alongside substantial infused‑therapy billing suggests a practice model combining frequent complex office visits with infusion care, increasing opportunities for coordinated oncology/hematology management.

The practice also reports substantial in‑office laboratory and phlebotomy activity that supports its infusion services: 36415 (phlebotomy), 85025 (CBC), and 80048 (BMP) all appear in the top codes and are described as typical, unremarkable volume despite high national percentiles, while 80076 (hepatic function panel) is described as notably above typical national volume. This pattern indicates routine lab monitoring is an integrated part of the care pathway, with some lab tests performed at volumes above typical peers.

Infusion administration and supportive medication codes (96413, 96365, 96367, J1627, J1449, Q5122) appear throughout the top codes and are consistently labeled as typical, unremarkable volume; these entries corroborate the provider’s operational capability to deliver repeated infusions and supportive oncology therapies. The presence of multiple administration codes alongside high‑value injectable drugs reinforces an infusion‑center workflow.

The provider’s NPI was enumerated on 2013-06-20 (~13 years ago), indicating an established Medicare billing history; combined with $2.7M in lifetime Medicare revenue, this tenure supports the interpretation of a stable, infusion‑focused practice rather than a newly formed operation. For payers and competitors, this profile signals an experienced regional player with concentrated oncology infusion revenue and selectively strong national standing on specific drug codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

81 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	20,000	$40	$860K
J0897	Injection, denosumab, 1 mg	22,740	$20	$409.3K
J1930	Injection, lanreotide, 1 mg	8,160	$40	$359K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	5,830	$40	$209.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,190	$90	$194.6K
J1627	Injection, granisetron, extended-release, 0.1 mg	12,700	$10	$63.5K
J1449	Injection, eflapegrastim-xnst, 0.1 mg	2,510	$30	$62.7K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	540	$90	$49.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	430	$100	$41K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	50	$720	$37.2K

Showing 1–10 of 81

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 81 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Robert Collins — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

81 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	14	30	19,700	$40	$832K
J1930	1	10	6,960	$40	$306.5K
J1569	4	20	3,860	$40	$161.4K
J1449	10	10	4,090	$30	$98.8K
J0897	8	250	2,400	$20	$91.2K
J3490	28	50	70	$510	$57.7K
Q5122	7	10	540	$90	$55.6K
J1627	1	10	10,400	$1	$46.3K
J1439	22	30	42,750	$1	$42.3K
78815	80	120	80	$220	$25.8K

Showing 1–10 of 81

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Collins, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Charles Butler	SC	Internal Medicine Physician	$3.8M	$0
Jill Sullivan	SC	Internal Medicine Physician	$3.4M	$0
Woodrow Coker	SC	Hospitalist Physician	$2.6M	$0
South Carolina Oncology Assoc PA	SC	Hematology & Oncology Physician	$0	$2.5M
Scott Sommers	SC	Hematology & Oncology Physician	$2.3M	$0
Mohamed El Geneidy	SC	Hematology & Oncology Physician	$2.1M	$0
Chaudhry Mushtaq	SC	Hematology & Oncology Physician	$2M	$0
Anne Hutchison	SC	Hematology & Oncology Physician	$2M	$0
Steven Minter	SC	Internal Medicine Physician	$1.9M	$0
Belmond Community Hospital	IA	Rural Health Clinic/Center	$0	$1.9M

Nearby Providers

Other providers in the same ZIP code as Robert Collins, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prisma Health Medical Group-midlands	SC	Multi-Specialty Clinic/Center	$0	$77.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$74.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$68.3M
South Carolina Department Of Mental Health Accounting Office	SC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$36M
Carolina Pediatrics & Adolescent Care, PA	SC	Pediatrics Physician	$0	$12.3M
Sc House Calls Inc	SC	Family Medicine Physician	$0	$11.6M
Prisma Health Medical Group-midlands	SC	Orthopaedic Surgery Physician	$0	$8.7M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$7.4M
Prisma Health-midlands	SC	Emergency Medicine Physician	$0	$6.8M
Prisma Health Medical Group-midlands	SC	Developmental - Behavioral Pediatrics Physician	$0	$5.9M

Robert Collins — Billing Profile & Reimbursement Data

Sign up for Robert Collins — Billing Profile & Reimbursement Data policy alerts

Robert Collins — Billing Profile & Reimbursement Data

Sign up for Robert Collins — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References